Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesDiseases and Disorders of the Female Reproductive SystemDRG 761-menstrual-and-other-female-reproductive-system-disorders-without-cc-mcc
    Ask Trek AI about this page

    Menstrual and Other Female Reproductive System Disorders without CC/MCC: Inpatient Reimbursement Overview

    DRG 761 addresses menstrual and other female reproductive system disorders without Complication or Comorbidity or Major Complication or Comorbidity, covering uncomplicated gynecologic medical and surgical admissions. It matters for inpatient reimbursement because it identifies lower-severity cases with correspondingly lower Medicare payments and helps determine payment classification for hospitals.

    Customize your policy alerts

    Sign up for drg 761 policy alerts

    Get alerted when payer policies referencing 761 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 761 Overview

    DRG 761 covers hospital admissions for menstrual and other female reproductive system disorders without Complication or Comorbidity or Major Complication or Comorbidity. Typical cases include noncomplicated procedures and medical management for conditions such as abnormal uterine bleeding, benign adnexal masses, and certain gynecologic pain syndromes. This Diagnosis-Related Group groups patients with lower expected resource use, which affects average inpatient payment under Medicare payment policies. Understanding the clinical scope aids coding, billing, and reimbursement classification.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Acute procedural and perioperative management studies: Trials assessing short-term procedural interventions (for example, endometrial ablation, hysteroscopy-guided polypectomy, or minimally invasive surgical management of symptomatic fibroids) compare different techniques, anesthesia protocols, or perioperative medical regimens in premenopausal and perimenopausal patients admitted for heavy menstrual bleeding or other non-malignant reproductive tract disorders. These studies enroll patients presenting with significant symptoms requiring inpatient or same-day surgical treatment and measure metrics such as hemostasis success, intraoperative blood loss, transfusion need, length of stay, and early complication rates. Findings directly inform hospital resource utilization, operative pathway standardization, and reimbursement considerations for DRG 761 by clarifying which approaches reduce complications and short-stay admissions.
    • Comparative effectiveness and symptom-control pharmacotherapy trials: Randomized or pragmatic trials comparing pharmacologic strategies (for instance hormonal regimens, antifibrinolytics, or novel non-hormonal agents) for controlling heavy menstrual bleeding, dysmenorrhea, or other benign reproductive disorders in outpatient-eligible but recently hospitalized patients. These studies focus on reproductive-aged patients with recurrent symptoms that led to recent inpatient evaluation, assessing reductions in bleeding days, need for future procedures, quality-of-life scores, and avoidance of rehospitalization over several months. Results are relevant to payers and providers because effective medical management that reduces readmissions and procedure rates can lower overall costs associated with DRG 761 and guide coverage and step-therapy policies.
    • Health services, care-transition, and long-term outcomes research: Observational cohort studies or implementation trials evaluating discharge planning, outpatient follow-up pathways, patient education, and long-term outcomes (including return visits, subsequent procedures, fertility outcomes, and patient-reported symptom resolution) for patients hospitalized for benign menstrual and other female reproductive system disorders. These studies typically enroll diverse inpatient populations across hospitals to identify predictors of unplanned readmission, disparities in access to conservative versus surgical care, and the impact of coordinated outpatient care on downstream utilization over 6–12 months. This research informs hospital quality metrics, DRG-based cost containment strategies, and payer decisions about investment in transitional care programs that can reduce avoidable readmissions and optimize allocation of resources for this patient group.

    Related Codes

    734-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITH-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy with CC/MCC: Inpatient Reimbursement Overview

    735-PELVIC-EVISCERATION-RADICAL-HYSTERECTOMY-AND-RADICAL-VULVECTOMY-WITHOUT-CC-MCC

    Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview

    736-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    737-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    738-UTERINE-AND-ADNEXA-PROCEDURES-FOR-OVARIAN-OR-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Ovarian or Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    739-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with MCC: Inpatient Reimbursement Overview

    740-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITH-CC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy with CC: Inpatient Reimbursement Overview

    741-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-OVARIAN-AND-NON-ADNEXAL-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Ovarian and Non-Adnexal Malignancy without CC/MCC: Inpatient Reimbursement Overview

    742-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITH-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy with CC/MCC: Inpatient Reimbursement Overview

    743-UTERINE-AND-ADNEXA-PROCEDURES-FOR-NON-MALIGNANCY-WITHOUT-CC-MCC

    Uterine and Adnexa Procedures for Non-Malignancy without CC/MCC: Inpatient Reimbursement Overview

    Showing 1–10 of 24

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.